Core One Labs’ (COOL.C) wholly-owned subsidiary Vocan Biotechnologies has entered into a term sheet with Vocan Brazil Biotechnologies (Vocan Brazil) for the licensing of its proprietary technology, biosynthesized psilocybin….
Psychedelics
At a time when many cannabis companies are enjoying bursts of investor interest, management at BC-based extractor Pure Extracts (PULL.C) must be getting frustrated as they roll out new…
Koios (KBEV.C) Fit Soda and nootropic beverages have been approved for placement at Sprouts Farmers Market. Sprouts will be picking up all nine stock-keeping units (SKUs) of Koios Beverages….
Mind Cure Health (MCUR.C) started their first stage of manufacturing pharma-grade ibogaine for both preclinical and clinical research today, according to a press release. Ibogaine is a psychoactive compound…
Cybin (CYBN.NE) has announced they have been uplisted, moving from the OTC Pink to the OTCQB Venture Market, and will begin trading on the OTCQB when the market opens…
Koios Beverage Corp. beverages will be made available at select Drug Emporium stores in Texas starting this month. These beverages include all five flavors of Koios nootropic drink and…
Mind Cure Health Inc. has completed its initial strategic equity investment. The investment equates to approximately 13-per-cent ownership in ATMA Journey Centers Inc. in accordance with the terms specified…
Psyched Wellness Ltd. (PSYC.C) has put out a press release showing that a maximum tolerated dosage (MTD) study of their muscimol extract (AME-1) has yielded positive results. The study…
Mydecine (MYCO.C), an upcoming biopharma and life sciences company advocating for the therapeutic use of psychedelic mushrooms, has successfully completed the world’s first legal international export of psilocybin mushrooms….
Supersized bought deal Field Trip (FTRP.CN) announced on Friday that it raised a whopping $95.3M CAD through a bought deal. The deal was originally for proceeds of $50M CAD…